Huohui Ou

525 total citations
16 papers, 405 citations indexed

About

Huohui Ou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huohui Ou has authored 16 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Huohui Ou's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Huohui Ou is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Huohui Ou collaborates with scholars based in China. Huohui Ou's co-authors include Dinghua Yang, Yu Huang, Leyang Xiang, Xianghong Li, Xincheng Liu, Zhanjun Chen, Xianghong Li, Qingbo Liu, Jie Lin and Jie Yao and has published in prestigious journals such as Oncotarget, Digestive Diseases and Sciences and Cancer Science.

In The Last Decade

Huohui Ou

16 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huohui Ou China 10 280 212 97 81 32 16 405
Wenxuan Wu China 8 314 1.1× 301 1.4× 114 1.2× 64 0.8× 47 1.5× 14 461
Ram C. Shankaraiah Italy 10 188 0.7× 147 0.7× 56 0.6× 95 1.2× 17 0.5× 11 339
Nicole P. Ho Hong Kong 6 265 0.9× 213 1.0× 46 0.5× 137 1.7× 31 1.0× 9 453
Kunming Wen China 13 287 1.0× 151 0.7× 70 0.7× 136 1.7× 36 1.1× 29 417
Baocun Sun China 8 298 1.1× 231 1.1× 44 0.5× 100 1.2× 13 0.4× 9 399
Zhimin Geng China 12 238 0.8× 177 0.8× 45 0.5× 82 1.0× 87 2.7× 19 394
Chun‐Hua Wang China 14 223 0.8× 129 0.6× 49 0.5× 126 1.6× 27 0.8× 20 413
Hee Doo Yang South Korea 13 479 1.7× 279 1.3× 61 0.6× 80 1.0× 16 0.5× 18 607

Countries citing papers authored by Huohui Ou

Since Specialization
Citations

This map shows the geographic impact of Huohui Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huohui Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huohui Ou more than expected).

Fields of papers citing papers by Huohui Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huohui Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huohui Ou. The network helps show where Huohui Ou may publish in the future.

Co-authorship network of co-authors of Huohui Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Huohui Ou. A scholar is included among the top collaborators of Huohui Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huohui Ou. Huohui Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zeng, Xiaokang, Huohui Ou, Chong Zeng, et al.. (2023). Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report. Frontiers in Oncology. 13. 1175707–1175707. 2 indexed citations
2.
Chen, Zhanjun, Leyang Xiang, Huohui Ou, et al.. (2022). TGF-β1 induced deficiency of linc00261 promotes epithelial–mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3. Journal of Translational Medicine. 20(1). 75–75. 10 indexed citations
3.
Zeng, Chong, Jie Lin, Ketao Zhang, et al.. (2022). SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling. Cancer Science. 113(11). 3766–3775. 94 indexed citations
4.
Ou, Huohui, Qingbo Liu, Jie Lin, et al.. (2021). Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p. Digestive Diseases and Sciences. 66(11). 3903–3915. 5 indexed citations
5.
Chen, Zhanjun, Leyang Xiang, Zhigang Hu, et al.. (2021). Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcription.. American Journal of Cancer Research. 11(1). 277–296. 14 indexed citations
6.
Xiang, Leyang, Xiaoting Huang, Siqi Wang, et al.. (2020). Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1. Cancer Science. 111(11). 4102–4117. 6 indexed citations
7.
8.
Ou, Huohui, Zhanjun Chen, Leyang Xiang, et al.. (2019). Frizzled 2‐induced epithelial‐mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma. Cancer Science. 110(4). 1169–1182. 36 indexed citations
9.
Ou, Huohui, Yu Huang, Leyang Xiang, et al.. (2018). Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma. Digestive Diseases and Sciences. 63(9). 2373–2380. 56 indexed citations
10.
Xiang, Leyang, et al.. (2017). [Expression of Wnt5b in patients with HBV-related hepatocellular carcinoma and its clinical significance].. PubMed. 37(8). 1071–1077. 1 indexed citations
11.
Ou, Huohui, Xincheng Liu, Leyang Xiang, et al.. (2017). NVM-1 predicts prognosis and contributes to growth and metastasis in hepatocellular carcinoma.. PubMed. 7(3). 554–564. 3 indexed citations
12.
13.
Liu, Xincheng, Huohui Ou, Leyang Xiang, et al.. (2017). Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Oncotarget. 8(6). 10510–10522. 31 indexed citations
14.
Liu, Xincheng, Yu Huang, Huohui Ou, et al.. (2016). Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma. Digestive and Liver Disease. 48(8). 953–960. 41 indexed citations
15.
Liu, Xincheng, et al.. (2016). [Positive circulating tumor cells in the peripheral blood may indicate a poor prognosis in patients with hepatocellular carcinoma].. PubMed. 36(8). 1134–9. 5 indexed citations
16.
Liao, Hui, Yu Huang, Xincheng Liu, et al.. (2015). Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma.. PubMed. 5(1). 125–39. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxuan Wu Breakdown of academic impact, for papers by Ram C. Shankaraiah Breakdown of academic impact, for papers by Nicole P. Ho Breakdown of academic impact, for papers by Kunming Wen Breakdown of academic impact, for papers by Baocun Sun Breakdown of academic impact, for papers by Zhimin Geng Breakdown of academic impact, for papers by Chun‐Hua Wang Breakdown of academic impact, for papers by Hee Doo Yang
Rankless by CCL
2026